Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Before you get a good answer, sometimes you need to ask the right question. The Priority Setting Partnership (PSP) for Hip and Knee Replacement for Osteoarthritis (OA) reached the end of its process in March this year, producing a list of ten priority areas for further research funding. These are questions that the combined group of healthcare professionals and patients / carers have concluded need addressing first to help continued progress in treating this area of patient health.

Before you get a good answer, sometimes you need to ask the right question. The Priority Setting Partnership (PSP) for Hip and Knee Replacement for Osteoarthritis (OA) reached the end of its process in March this year, producing a list of ten priority areas for further research funding. These are questions that the combined group of healthcare professionals and patients / carers have concluded need addressing first to help continued progress in treating this area of patient health.

An article in this week's Telegraph uses this as proof that good research starts off with the patients. The project is the 20th supported by the James Lind Alliance, who have previously focused on conditions from asthma to schizophrenia, moving each area of research forward.

The ten priorities, which will be addressed by NDORMS and others, are:

  1. What are the most important patient and clinical outcomes in hip and knee replacement surgery, for people with OA, and what is the best way to measure them?
  2. What is the optimal timing for hip and knee replacement surgery, in people with OA, for best post-operative outcomes?
  3. In people with OA, what are the pre-operative predictors of post-operative success (and risk factors of poor outcomes)?
  4. What (health service) pre-operative, intra-operative, and post-operative factors can be modified to influence outcome following hip and knee replacement?
  5. What is the best pain control regime pre-operatively, peri-operatively and immediately post-operatively for hip and knee joint replacement surgery for people with OA?
  6. What are the best techniques to control longer-term chronic pain and improve long-term function following hip and knee replacement?
  7. What are the long-term outcomes of non-surgical treatments compared with operative treatment for patients with advanced knee/hip OA?
  8. What is the most effective pre- and post-operative patient education support and advice for improving outcomes and satisfaction for people with OA following hip/ knee replacement?
  9. What is an ideal post-operative follow up period and the best long-term care model for people with OA who have had hip/knee replacement?
  10. What is the best way to protect patients from the risk of thrombotic (blood clots, bleeding) events associated with hip/knee replacement?

Similar stories

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Womens Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.